Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > Understanding Proph

<< Previous

Bullboard Posts

Next >>

Comment by Ciaoon Mar 10, 2021 3:10pm

71 Views

Post# 32764786

RE:RE:RE:Understanding Proph

That is correct. They can pivot and produce an inhalable Y-BG COVID therapeutic if clinical studies (esp. Phase 1/2) support it.

archeo753 wrote: I may be completely wrong but it seems to me the German plant opportunity is connected to the immunity boosting properties of PGX-YBG as a health suppliment and that the COVID angle is just a side benefit that was discovered in testing with McMaster U when they were looking for a carier for other drugs. So regardless of whether there is ever a YBG COVID inhaleable theraputic there is a potential market for Ceapro's YBG of $100 million. This number was stated by Gilles in the presentation yesterday. Hopefully we'll eventually get a news release clearing some of this up.

trek01 wrote: Didn't they start working on the germany plant before covid came?